Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Boston Scientific has announced that the US District Court of Marshall, Texas, has found two patents of Medtronic unenforceable for inequitable conduct during the prosecution of the patents before the US Patent and Trademark Office.
Subscribe to our email newsletter
A jury had previously found that certain Boston Scientific balloon catheters and stent delivery systems infringed three Medtronic patents and that the patents were valid. The jury awarded damages of $250 million.
As a result of this decision, the damages are reduced to approximately $19 million. Following a prior decision by the court, Medtronic and Boston Scientific had already agreed to reduce the jury verdict to approximately $186 million.
Boston Scientific plans to appeal the remaining $19 million damage award to the US Court of Appeals for the Federal Circuit in Washington, DC. The company is confident it will prevail on appeal.